Korea and Kuwait Launches Boost Bemfola For Richter

Higher sales of its Bemfola follitropin biosimilar following recent launches in Korea and Kuwait helped Gedeon Richter to raise its first-quarter Pharmaceutical sales by 2.7%.  

Korea_Kuwait_Flags
Korea and Kuwait are the latest countries in which Gedeon Richter has launched its Bemfola follitropin biosimilar • Source: Shutterstock

More from Biosimilars

More from Products